
Brincidofovir
CAS No. 444805-28-1
Brincidofovir ( CMX 001 | Cidofovir HDP )
产品货号. M14523 CAS No. 444805-28-1
Brincidofovir(CMX 001;Cidofovir HDP)是无环核苷酸磷酸酯的脂质缀合物。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
5MG | ¥932 | 有现货 |
![]() ![]() |
10MG | ¥1401 | 有现货 |
![]() ![]() |
25MG | ¥2819 | 有现货 |
![]() ![]() |
50MG | ¥4228 | 有现货 |
![]() ![]() |
100MG | ¥5419 | 有现货 |
![]() ![]() |
200MG | ¥7719 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称Brincidofovir
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述Brincidofovir(CMX 001;Cidofovir HDP)是无环核苷酸磷酸酯的脂质缀合物。
-
产品描述Brincidofovir (CMX 001;Cidofovir HDP) is a lipid conjugate of the acyclic nucleotide phosphonate, cidofovir that shows activity against all five families of dsDNA viruses that cause human morbidity and mortality, including orthopoxviruses such as variola virus, the cause of human smallpox; has a number of advantages for treatment of smallpox in an emergency including greater potency in vitro against all dsDNA viruses that cause human disease, a high genetic barrier to resistance, convenient oral administration as a tablet or liquid, and no evidence to date of nephrotoxicity in either animals or humans. CMV Infection Phase 3 Clinical.
-
体外实验——
-
体内实验——
-
同义词CMX 001 | Cidofovir HDP
-
通路Microbiology/Virology
-
靶点CMV
-
受体CMV
-
研究领域Infection
-
适应症CMV Infection
化学信息
-
CAS Number444805-28-1
-
分子量561.701
-
分子式C27H52N3O7P
-
纯度>98% (HPLC)
-
溶解度DMSO : 1 mg/mL 1.78 mM
-
SMILESCCCCCCCCCCCCCCCCOCCCOP(=O)(COC(CN1C=CC(=NC1=O)N)CO)O
-
化学全称3-(hexadecyloxy)propyl hydrogen ((((S)-1-(4-amino-2-oxopyrimidin-1(2H)-yl)-3-hydroxypropan-2-yl)oxy)methyl)phosphonate
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Toth K, et al. Proc Natl Acad Sci U S A. 2008 May 20;105(20):7293-7.
2. Lanier R, et al. Viruses. 2010 Dec;2(12):2740-2762.
3. McMullan LK, et al. Antiviral Res. 2016 Jan;125:71-8.
产品手册




关联产品
-
Brincidofovir
Brincidofovir(CMX 001;Cidofovir HDP)是无环核苷酸磷酸酯的脂质缀合物。
-
CEF20
CEF20, a CEF control peptide pool, is an HLA-A*0201-restricted epitope from cytomegalovirus pp65 (495-503).
-
Cidofovir dihydrate
西多福韦二磷酸酯的前药,通过选择性抑制病毒 DNA 聚合酶来抑制巨细胞病毒 (CMV) 病毒复制。